These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21074014)

  • 21. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.
    Sarkar NN
    J Obstet Gynaecol; 2011 Nov; 31(8):703-7. PubMed ID: 22085058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
    Lyus R; Lohr P; Prager S;
    Contraception; 2010 May; 81(5):367-71. PubMed ID: 20399942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency contraception: Oral and intrauterine options.
    Black KI; Hussainy SY
    Aust Fam Physician; 2017 Oct; 46(10):722-726. PubMed ID: 29036770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine contraception: an update.
    Bhathena RK; Guillebaud J
    J Obstet Gynaecol; 2008 Apr; 28(3):262-5. PubMed ID: 18569464
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency contraception: a review.
    Corbelli J; Bimla Schwarz E
    Minerva Ginecol; 2014 Dec; 66(6):551-64. PubMed ID: 25313947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An emergency contraception algorithm based on risk assessment: changes in clinicians' practice and patients' choices.
    McKay RJ; Gilbert L
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):201-6. PubMed ID: 23430815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on emergency contraception.
    Fok WK; Blumenthal PD
    Curr Opin Obstet Gynecol; 2016 Dec; 28(6):522-529. PubMed ID: 27676405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy.
    Royer PA; Turok DK; Sanders JN; Saltzman HM
    J Womens Health (Larchmt); 2016 Oct; 25(10):1038-1043. PubMed ID: 27032057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity.
    Meng CX; Marions L; Byström B; Gemzell-Danielsson K
    Hum Reprod; 2010 Apr; 25(4):874-83. PubMed ID: 20139427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency Contraception.
    Batur P; Kransdorf LN; Casey PM
    Mayo Clin Proc; 2016 Jun; 91(6):802-7. PubMed ID: 27261868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study.
    Novikova N; Weisberg E; Stanczyk FZ; Croxatto HB; Fraser IS
    Contraception; 2007 Feb; 75(2):112-8. PubMed ID: 17241840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.